Pharma/ATMP

As the field of personalized cell and gene therapies rapidly advances, so does the need for rigorous quality control measures. Quality control in biopharmaceutical and ATMP production is essential to ensure the safety, efficacy and quality of these advanced therapies. Unlike conventional pharmaceuticals, which are often chemically synthesized and standardized, ATMPs are biological products derived from living cells or tissues, making them inherently more complex and variable. Therefore, robust quality control measures are necessary throughout the manufacturing process to mitigate risks and ensure product quality.

Minerva Biolabs supports you with innovative product solutions for ensuring the quality control of your biopharmaceutical/ATMP product in compliance to regulatory guidelines with:

• Regulatory mycoplasma testing
• Residual host cell DNA testing
• Vector copy number determination*
• Complete pyrogen testing*

(* according products will be released soon. Subscribe to our newsletter to get notified.)